Introduction to the design of diagnostic criteria Joop P van de Merwe Dept. of Immunology & Internal...
-
date post
19-Dec-2015 -
Category
Documents
-
view
216 -
download
0
Transcript of Introduction to the design of diagnostic criteria Joop P van de Merwe Dept. of Immunology & Internal...
introduction to the design of diagnostic criteria
Joop P van de MerweDept. of Immunology
& Internal MedicineErasmus MC Rotterdam
ESSIC Meeting Baden 16-18 June 2005
2 * Fries JF et al. Arthritis Rheum 1994;37:454-62
Types and purposes of criteria*
Type Purpose
Classification criteria To separate those with a specific disease from those without the disease
Subclassification criteria To separate diseases or subsets within a disease cluster
Prognostic criteria To separate subjects with good or potentially favorable outcomes from those with bad outcomes
Status indexes To assess present disease activity or accumulated damage from the disease
Activity indexes (implies reversibility)
To estimate current disease activity status
Damage indexes (implies irreversibility)
To estimate accumulated damage from the disease
Outcome criteria To measure the overall impact of a disease and to serve as dependent variables for clinical studies
3
* Fries JF et al. Arthritis Rheum 1994;37:454-62 (modified)
CLASSIFICATION CRITERIA*
Classification criteria separate patients with the disease from the general population and from patients with potentially confusable conditions
Persons with Diseases
Persons with ConfusableDiseases
All Persons
Persons with Target
Disease
4
overlapping features
example: systemic autoimmune diseases
the problem
5
systemic autoimmune diseases (1)
• rheumatoïd arthritis• Sjögren's syndrome• systemic lupus erythematosus (SLE)• antiphospholipid syndrome (APS)• mixed connective tissue disease (MCTD)• systemic sclerosis (scleroderma, CREST-syndrome) • polymyositis / dermatomyositis• relapsing polychondritis
examples
6
possible features
clinical
• arthritis / arthralgia• vasculitis• fever• Raynaud's phenomenon• fatigue• various renal diseases
laboratory
• increased ESR, CRP• anaemia • leukopenia• rheumatoid factor• ANA• trombopenia
systemic autoimmune diseases (2)
not specific
for
one single disease
not specific
for
one single disease
7
possible accompaning organspecific autoimmune diseases
• atrophic gastritis - pernicious anaemia• Hashimoto's disease• keratoconjunctivitis sicca • lymfocytic interstitial pneumonitis • myositis • pericarditis, pleuritis • peripheral neuropathy • uveitis (iritis, iridocyclitis)• scleritis • interstitial cystitis
systemic autoimmune diseases (3)
no combination is specific
for one single disease
8
how do you recognize them ?
systemic autoimmune diseases (4)
9
people
how do you recognize them ?
each person
has a face
10
people
how do you recognize them ?
none of the
parts of the
face is unique,
but the
combination is
11
people
how do you recognize them ?
none of the
parts of the
code is unique,
but the
combination is
12
each autoimmune disease
has its own "face"
how do you recognize them ?
systemic autoimmune diseases (4)
13
systemic autoimmune diseases (5)
characteristic feature
specific way it affects the lacrimal and salivary glandsspecific way it affects the joints specific way it affects the skin specific way it affects the skin
combination of clinical symptoms and anti-RNP specific way it affects the skin combination of symptoms
disease
Sjögren's syndrome
rheumatoid arthritissystemic lupus erythematosus subacute cutaneous lupus erythematosus mixed connective tissue disease (MCTD)systemic sclerosis (scleroderma) CREST syndrome
characteristic features
14
characteristic features
what are the characteristic features of IC ?
• what is the consequence of the PBS/IC concept ?
ICS definition of PBS/IC
PBS: "suprapubic pain related to bladder filling, accompanied by other symptoms such as increased daytime and nighttime frequency in the absence of infection or other pathology"
IC: above with "typical cystoscopic and histological features"
15
characteristic features
what are the "typical cystoscopic and histological features of IC" ?
what has happened to urgency ?
ICS definition of IC may be written as:
suprapubic pain related to bladder filling, accompanied by other symptoms such as increased daytime and nighttime frequency with typical cystoscopic and histological features in the absence of infection or other pathology
what are the characteristic features of IC ?
16
characteristic features
what are the "typical cystoscopic and histological features of IC" ?
Cysto features: Hunner's ulcer or low capacity
epithelial denudation, submucosal inflammation, granulation tissue, edema, congestion, haemorrhage; detrusor fibrosis (and myopathy)
increased mast cell number & activation and neuronal staining
from: Hanno P, Burks D. Painful bladder syndrome / interstitialcystitis. Course 93 IC, AUA 2005 Annual Meeting, San Antonio, TX, May 21-26,2005
17
characteristic features
Cysto features: Hunner's ulcer or low capacity
epithelial denudation, submucosal inflammation, granulation tissue, edema, congestion, haemorrhage; detrusor fibrosis (and myopathy)
increased mast cell number & activation and neuronal staining
from: Hanno P, Burks D. Painful bladder syndrome / interstitialcystitis. Course 93 IC, AUA 2005 Annual Meeting, San Antonio, TX, May 21-26,2005
does this matter as long as the combination is unique ?
but these are not unique for IC !
18
PBS / IC concept
PBS
IC
PBS
orIC
IC has "typical" cystoscopic and histological features of IC in addition tosuprapubic pain and frequency
19
gold standard
gold standard = diagnosis by experts
why ?- the diagnosis by experts is the best standard we have as long as the cause of a disease is unknown
advantage- non-experts can diagnose a disease as if they were experts (skill level)- diagnoses are made on the same basis by experts and non-experts (uniformity)- rules are based on information from many experts (acceptance and support)
20 Arthritis Rheum 1990;33:1137-44
classification methods (1)
classification tree
the classification tree is constructed by repeated splits of groups into 2 descendant subgroups
21 Arthritis Rheum 1990;33:1137-44
classification tree
pro
• items may be polychotomous or continuous
• nonparametric: no reference to a model for the
relationship between classification items and disease
status
• high information content - classified groups of subjects in
studies may be referred to the exact classifying subgroup
of the tree
22
"number of criteria present rule"
Ann Rheum Dis 2002;61:554-8
23 Arthritis Rheum 1990;33:1137-44
classification methods (2)
con• simple definitions (+/-): - all items are given equal weight - all items must be dichotomous (+/-)
little insight into the characteristics of a classified patient group
pro• simple definitions (+/-): easy application
"number of items present rule"
24
1. collect what information (symptoms and signs*) is used
by experts to diagnose IC and
differentiate IC from confusable diseases
for both men and women
suggested approach in a multicentre study
* requires definitions and decisions on data format
25
2. collection of data from
patients with IC and
patients with confusable diseases
to define classification criteria for IC
(training phase)
sensitivity specificity
suggested approach in a multicentre study
calculate an optimal combinationon the basis of how many false negative and false positivediagnoses we accept
26
3. validation with new patient groups
suggested approach in a multicentre study
the same database can be used to create
number of items present rule
for clinical diagnoses and a
classification tree
for scientific studies
27
data may be
- continuous
avoid entry of cut-off points for continuous data
but have the statistical analysis decide
- categorical
data format
28
tests to be evaluated for their diagnostic value
should be done in all patients with IC and confusable
diseases
1. antiproliferative factor
2. ................................
3. ................................
to be evaluated ….
29
1. decision on broad definition of IC
PBS + "typical" cystoscopy and/or histology
2. select diseases with which IC can be confused
(confusable diseases, CD)
list to be discussed this morning
3. what information is needed to distinguish IC from CD:
follows from (2) but needs discussion and decision
4. decision on what percentage of false negative and
false positive diagnoses we accept
summary & conclusions (1)
30
5. decision on gold standard for the diagnosis IC
diagnosis by experts
6. decision on methods of classification
classification tree and
"number of items present rule"
7. decision to perform a small pilot to test procedures
8. decision on tests to be evaluated
APF test
summary & conclusions (2)
31
consensus on IC